Lexaria Bioscience (LEXX) Annual Balance Sheets

Annual · GAAP · USD millions
Access LEXX quarterly Balance Sheets →
The table below presents a historical view of Lexaria Bioscience's balance sheet, supporting analysis of financial position trends.
Annual Report, GAAP in USD millions
ITEM
(Aug 31 2025)
(Aug 31 2024) (Aug 31 2023) (Aug 31 2022) (Aug 31 2021)
Assets
Cash & cash equivalent0.00
Short-term Investments, Total0.02
Other Short-term Investments AS0.14
Cash & Short-term Investments0.00
Accounts receivable0.37
Inventories0.00
Other Current Assets1.80
Prepaid Expense And Other Assets Current1.13
Total Current Assets3.47
Equipment/Property/Plant Net0.23
Intangible Assets0.31
Long-term investments0.06
Deferred Tax Assets, Property, Plant and Equipment0.00
Other Assets, Noncurrent0.17
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents1.80
Intangible Assets Gross Excluding Goodwill-
Total Assets4.18
Liabilities
Accounts Payable and Accrued Liabilities, Current LI1.46
Loans Payable, Current NO0.00
Other Liabilities, Current0.00
Deferred Revenue DE0.00
Total Current Liabilities1.49
Total Long-term Debt0.00
Other liabilities, Noncurrent0.00
Finance Lease Liability Current0.03
Operating Lease Liability Noncurrent0.08
Finance Lease Liability Noncurrent-
Total Liabilities1.57
Stockholders' Equity
Equity Attributable To Shareholders Of The Company-
Common Stock Value0.02
Additional Paid In Capital Common Stock66.50
Retained Earnings / Accumulated Deficit-63.46
Other Equity-0.45
Common Stockholder's Equity2.61
Non-controlling interests & other0.00
Total Stockholder's Equity2.60
Liabilities & Stockholder's Equity4.18
4 historic quarters locked

Sign in to unlock the full Lexaria Bioscience balance sheet history.

About Lexaria Bioscience Corp Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-K (Period: 20250831)
  • Filed with the SEC: November 26, 2025
  • Source: lxrp_10k.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001640334-25-002225

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License